Poor targeting of therapeutics leading to severe adverse effects on normal tissues is
considered one of the obstacles in cancer therapy. To help overcome this, nanoscale drug …

Abstract P-glycoprotein (P-gp) is a drug efflux transporter that triggers doxorubicin (DOX)
resistance. In this review, we highlight the molecular avenues regulating P-gp, such as Nrf2 …

An important motivation for the use of nanomaterials and nanoarchitectures in cancer
therapy emanates from the widespread emergence of drug resistance. Although doxorubicin …

Recently, nanocarriers, including micelles, polymers, carbon-based materials, liposomes,
and other substances, have been developed for efficient delivery of drugs, nucleotides, and …

Cancer is the second leading cause of death in the world, behind only cardiovascular
diseases, and is one of the most serious diseases threatening human health nowadays …

Nanomedicine is a branch of medicine using nanotechnology to prevent and treat diseases.
Nanotechnology represents one of the most effective approaches in elevating a drug's …

Development of a functional sorbent for effective crude oil absorption is essential to address
large-scale spilling incidents. Herein, we demonstrate a facile method for preparing a …

Cutaneous melanoma is one of the most common malignant skin cancer with high lethality.
Chemotherapy and photothermal therapy are important and extensively studied treatment …

Chemotherapy is still the most direct and effective means of cancer therapy nowadays. The
proposal of drug delivery systems (DDSs) has effectively improved many shortcomings of …

Ciprofloxacin (CIP), a potent anti-bacterial agent of the fluroquinolone family, shows poor
solubility and permeability, thus leading to the development of intracellular pathogens …